Induction of heme oxygenase-1 protects against podocyte apoptosis under diabetic conditionsopen access
- Authors
- Lee, Sang Choel; Han, Seung Hyeok; Li, Jin Ji; Lee, Sun Ha; Jung, Dong-Sub; Kwak, Seung-Jae; Kim, Seung Hye; Kim, Dong Ki; Yoo, Tae-Hyun; Kim, Jin Hyun; Chang, Se-Ho; Han, Dae Suk; Kang, Shin-Wook
- Issue Date
- Oct-2009
- Publisher
- ELSEVIER SCIENCE INC
- Keywords
- apoptosis; diabetic nephropathy; heme oxygenase-1; high glucose; podocyte
- Citation
- KIDNEY INTERNATIONAL, v.76, no.8, pp 838 - 848
- Pages
- 11
- Indexed
- SCIE
SCOPUS
- Journal Title
- KIDNEY INTERNATIONAL
- Volume
- 76
- Number
- 8
- Start Page
- 838
- End Page
- 848
- URI
- https://scholarworks.gnu.ac.kr/handle/sw.gnu/26150
- DOI
- 10.1038/ki.2009.286
- ISSN
- 0085-2538
1523-1755
- Abstract
- Heme oxygenase-1 (HO-1) is an anti-oxidant enzyme normally upregulated in response to oxidant injury. Here we determined the role of HO-1 in podocyte apoptosis in glomeruli of streptozotocin-treated rats and in immortalized mouse podocytes cultured in media containing normal or high glucose. HO-1 expression, its activity, the ratio of Bax/Bcl-2 protein, and active caspase-3 fragments were all significantly higher in isolated glomeruli of diabetic rats and in high glucose-treated podocytes. These increases were inhibited by zinc protoporphyrin treatment of the rats or by HO-1 siRNA treatment of the podocytes in culture. The number of apoptotic cells was also significantly increased in the glomeruli of diabetic rats and in high glucose-treated podocytes. Inhibition of HO-1 accentuated the increase in apoptotic cells both in vivo and in vitro. Our findings suggest that HO-1 expression protects against podocyte apoptosis under diabetic conditions. Kidney International (2009) 76, 838-848; doi:10.1038/ki.2009.286; published online 5 August 2009
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Medicine > Journal Articles

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.